HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 289/2/C352    most recent 00111.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (18) Citing Articles via Google Scholar Google Scholar Articles by Pang, H. Articles by Gong, M. C. Search for Related Content PubMed PubMed Citation Articles by Pang, H. Articles by Gong, M. C.

RECEPTORS AND SIGNAL TRANSDUCTION

RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells

¹Department of Physiology and Graduate Center for Nutritional Sciences, University of Kentucky, Lexington, Kentucky; and ²Center for Cell Signaling, University of Virginia School of Medicine, Charlottesville, Virginia

Submitted 10 March 2005 ; accepted in final form 2 April 2005

Protein kinase C-potentiated phosphatase inhibitor of 17 kDa (CPI-17) mediates some agonist-induced smooth muscle contraction by suppressing the myosin phosphatase in a phosphorylation-dependent manner. The physiologically relevant kinases that phosphorylate CPI-17 remain to be identified. Several previous studies have shown that some agonist-induced CPI-17 phosphorylation in smooth muscle tissues was attenuated by the Rho kinase (ROCK) inhibitor Y-27632, suggesting that ROCK is involved in agonist-induced CPI-17 phosphorylation. However, Y-27632 has recently been found to inhibit protein kinase C (PKC)-, a well-recognized CPI-17 kinase. Thus the role of ROCK in agonist-induced CPI-17 phosphorylation remains uncertain. The present study was designed to address this important issue. We selectively activated the RhoA pathway using inducible adenovirus-mediated expression of a constitutively active mutant RhoA (V14RhoA) in primary cultured rabbit aortic vascular smooth muscle cells (VSMCs). V14RhoA caused expression level-dependent CPI-17 phosphorylation at Thr38 as well as myosin phosphatase phosphorylation at Thr853. Importantly, we have shown that V14RhoA-induced CPI-17 phosphorylation was not affected by the PKC inhibitor GF109203X but was abolished by Y-27632, suggesting that ROCK but not PKC was involved. Furthermore, we have shown that the contractile agonists thrombin and U-46619 induced CPI-17 phosphorylation in VSMCs. Similarly to V14RhoA-induced CPI-17 phosphorylation, thrombin-induced CPI-17 phosphorylation was not affected by inhibition of PKC with GF109203X, but it was blocked by inhibition of RhoA with adenovirus-mediated expression of exoenzyme C3 as well as by Y-27632. Taken together, our present data provide the first clear evidence indicating that ROCK is responsible for thrombin- and U-46619-induced CPI-17 phosphorylation in primary cultured VSMCs.

protein kinase C; signal transduction; adenovirus

This article has been cited by other articles:

				P. H. Ratz and A. S. Miner Role of Protein Kinase C{zeta} and Calcium Entry in KCl-Induced Vascular Smooth Muscle Calcium Sensitization and Feedback Control of Cellular Calcium Levels J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 399 - 408. [Abstract] [Full Text] [PDF]

				Y. M. Seok, I. Baek, Y.-H. Kim, Y.-S. Jeong, I.-J. Lee, D. H. Shin, Y. H. Hwang, and I. K. Kim Isoflavone Attenuates Vascular Contraction through Inhibition of the RhoA/Rho-Kinase Signaling Pathway J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 991 - 998. [Abstract] [Full Text] [PDF]

				D. W. Nuno, V. P. Korovkina, S. K. England, and K. G. Lamping RhoA Activation Contributes to Sex Differences in Vascular Contractions Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 1934 - 1940. [Abstract] [Full Text] [PDF]

				A. Maeda, Y.-i. Ozaki, S. Sivakumaran, T. Akiyama, H. Urakubo, A. Usami, M. Sato, K. Kaibuchi, and S. Kuroda Ca-independent phospholipase A2-dependent sustained Rho-kinase activation exhibits all-or-none response. Genes Cells, September 1, 2006; 11(9): 1071 - 1083. [Abstract] [Full Text] [PDF]

				H. Pang, Z. Guo, Z. Xie, W. Su, and M. C. Gong Divergent kinase signaling mediates agonist-induced phosphorylation of phosphatase inhibitory proteins PHI-1 and CPI-17 in vascular smooth muscle cells Am J Physiol Cell Physiol, March 1, 2006; 290(3): C892 - C899. [Abstract] [Full Text] [PDF]

				Z. Xie, W. Su, Z. Guo, H. Pang, S. R. Post, and M. C. Gong Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells Cardiovasc Res, February 1, 2006; 69(2): 491 - 501. [Abstract] [Full Text] [PDF]